Cargando…
Molecular and clinical studies in 107 Noonan syndrome affected individuals with PTPN11 mutations
BACKGROUND: Noonan syndrome (NS), an autosomal dominant developmental genetic disorder, is caused by germline mutations in genes associated with the RAS / mitogen-activated protein kinase (MAPK) pathway. In several studies PTPN11 is one of the genes with a significant number of pathogenic variants i...
Autores principales: | Athota, Jeevana Praharsha, Bhat, Meenakshi, Nampoothiri, Sheela, Gowrishankar, Kalpana, Narayanachar, Sanjeeva Ghanti, Puttamallesh, Vinuth, Farooque, Mohammed Oomer, Shetty, Swathi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068896/ https://www.ncbi.nlm.nih.gov/pubmed/32164556 http://dx.doi.org/10.1186/s12881-020-0986-5 |
Ejemplares similares
-
Molecular and clinical profiling in a large cohort of Asian Indians with glycogen storage disorders
por: Kumar, Tejashwini Vittal, et al.
Publicado: (2022) -
Noonan syndrome: rhGH treatment and
PTPN11
mutation
por: Wu, Xian, et al.
Publicado: (2023) -
Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation
por: Jongmans, Marjolijn C J, et al.
Publicado: (2011) -
KRAS Analysis in 34 Noonan Syndrome Patients without
PTPN11 Mutation
por: Yamamoto, Kaoru, et al.
Publicado: (2007) -
The Fetal Phenotype of Noonan Syndrome Caused by Severe, Cancer-Related PTPN11 Variants
por: Malniece, Ieva, et al.
Publicado: (2020)